Working with growth factors that exist in several forms at once: why a vegf antibody and a vegfa antibody are not interchangeable when the gene produces multiple isoforms, what a vegf elisa kit and a human vegf elisa kit actually measure once free and receptor bound pools are considered, how recombinant egf and other recombinant growth factors vary in activity between lots even at identical stated mass, and which controls make a growth factor measurement or a stimulation experiment reproducible

Getting reproducible growth factor work

1. Establish which isoforms your reagent sees. A gene producing several splice variants needs an antibody whose immunogen region is present in the variants you care about. A pan reagent and a variant specific reagent answer different questions and are sold under similar names.
2. Understand which pool the assay measures. Free ligand, total ligand after dissociation, and ligand in complex give very different numbers from the same sample. A kit that does not state which it measures cannot be compared with one that does.
3. Standardise sample handling for the analyte. Platelet release during collection, clotting and freeze thaw all change measured concentrations for several growth factors. Fix the tube type, the processing time and the aliquoting, and keep them constant across a study.
4. Titrate every new lot of recombinant protein. Specific activity varies between lots and between suppliers even at the same nominal mass, because folding, aggregation and carrier protein content differ. Run a dose response with each new lot rather than matching by mass.
5. Choose carrier free or carrier containing deliberately. Carrier protein stabilises dilute preparations and interferes with some downstream applications. Decide which you need and keep it consistent, because switching changes effective concentration.
6. Record lot with every experiment. For this class of reagent, lot is the variable most likely to explain an unexpected result. Recording it costs nothing and is the first thing an investigation needs.

Mass is not activity

A recombinant growth factor is quoted in micrograms and used for its biological effect, and the relationship between the two depends on how much of the preparation is correctly folded and monomeric. A lot with more aggregate delivers less activity at the same mass.

The practical consequence is that dose response should be re established with each lot. Laboratories that do this stop seeing unexplained shifts in their stimulation experiments.

What a measured concentration means

For ligands that circulate partly bound, a measured concentration is a property of the assay as much as of the sample. Comparing across kits, across studies or across matrices without stating the assay is comparing different quantities.

Report the kit, the standard and the sample handling with any concentration. It is the difference between a number someone can use and a number someone will have to repeat.

Common questions

Why do two ELISA kits give different concentrations?

Because they measure different pools and calibrate against different standards. Neither is necessarily wrong, and the practical response is to choose one kit for a study and report the kit and standard with the values.

Does isoform specificity matter?

Whenever the biology depends on which isoform is present, which for several growth factor families it does. Check the immunogen region against the isoform structure rather than trusting the gene name on the label.

Why does a new lot of recombinant protein behave differently?

Specific activity differs between lots because of folding, aggregation and carrier content. Titrating each lot against a dose response, rather than matching stated mass, is the only reliable approach.

How should samples be collected for growth factor measurement?

With a fixed tube type, a fixed time to processing and minimal freeze thaw, because several of these analytes are released or degraded during handling. The collection protocol is part of the method.

Browse by service class

• Compare Gene synthesis on advertised prices